期刊文献+

SD大鼠房颤模型的建立 被引量:52

Establishment of Artial Fibrillation Model in SD Rats
下载PDF
导出
摘要 目的研究一种发病机制,病理改变与临床接近且造模周期较短的大鼠房颤模型制备方法与技术。方法大鼠连续给药,经尾静脉注射乙酰胆碱-氯化钙混合液,每次给药后记录房颤持续时间。寻找能诱发稳定房颤的给药剂量和给药时间。电生理学方法观察正常和模型大鼠心房不应期的变化。结果CaCl210 mg/mL,乙酰胆碱66μg/mL模型大鼠从第4 d起房颤时间缓慢增长,7 d后趋于稳定。与正常组相比,模型大鼠心房肌ERP显著缩短(59.3 ms±5.8 ms)。结论CaCl210 mg/mL+乙酰胆碱66μg/mL混合液连续给予7 d诱导产生的大鼠房颤模型,其电生理学的病理变化与临床房颤相似,适用于化合物抗房颤活性筛选研究。 Objective To establish an artial fibrillation animal model in rats. Methods To establish the artial fibrillation model,mixed Ach-CaCl2solution was injected into the caudal veins of SD rats at different concentrations for 7 days. Electrocardiogram was recorded everyday before and after the treatment. The effective refractory period (ERP) of artial muscle was determined in the last day. Results The mixed solution of Ach-CaCl2 could induce a stable artial fibrillation at the concentration of CaCl2 10 mg/mL and Ach 66 μg/mL in rats. Duration time of artial fibrillation was enhanced at the first three days and became stable during the last four days. The ERP of artial muscle was 59.3 ± 5.8 ms in model group which was shorter than that in the normal group (77.3 ± 5.3 ms). Conclusion A stable artial fibrillation model in rats can be established by caudal vein injection of Ach-CaCl2 solution. This model is mimics the mechanism of artial fibrillation in human. It is simple and convenience to be used in screening the drugs for anti-artial fibrillation in small animals.
出处 《实验动物科学》 2009年第3期1-4,共4页 Laboratory Animal Science
基金 国家863计划课题(No.2007AA02Z307)
关键词 心房颤动 有效不应期 大鼠 Artial fibrillation Effective refractory period Rat
  • 相关文献

参考文献7

二级参考文献36

  • 1赵庆彦,黄从新.迷走神经对心房颤动影响的离子通道基础[J].中国心脏起搏与心电生理杂志,2005,19(2):147-149. 被引量:12
  • 2[1]Thomas SP, Ross DL. Induction of atrial fibrillation and flutter in dogs using methacholine[J]. J Interv Cardiol Electrophysiol,1999,3:301-305.
  • 3[2]Fareh S,Villemaire S,Nattel S.Importance of refractoriness heterogeneity in the enhanced vulnerability to atrial fibrillation induction caused by tachycardia-induced atrial electrical remodeling[J]. Circulation,1998,98:2202-2209.
  • 4[3]Wang J, Liu L, Feng J,et al. Regional and functional factors determining induction and maintenance of atrial fibrillation in dogs[J]. Am J Physiol,1996,273:H148-H158.
  • 5[4]Moe GK,Rheinboldt WC,Abildskov JA.A computer model of atrial fibrillation[J]. Am heart J,1964,67:200-220.
  • 6[3]Rupak Mukherjee Php,Amanda R Hemon BS,Abigails,et al.Selective Induction of Matrix Metalloproteinases and Tissue Inhibitor of Metalloproteinases in Atrial and Ventricular Myocardium in Patients With Atvial Fibrillation[J].Am/Cardiol,2006,97:532-537
  • 7[4]Xu J,Cui G,Esmailian F,et al.Atrial extracellular matrix remodeling and the maintenance of atrial fibrillation[J].Circulation,2004,109:363-368
  • 8[6]Beaudeux JL,Giral P,Bruckert E,et al.Matrix metalloproteinases,inflammation and atherosclerosis:therapeutic perspectives[J].Clin Cherm Lab Med,2004,42(2):12l-131
  • 9Ortiz J, Igarashi M, Gonzalez X, et al. A new, reliable atrial fibrillation model with a clinical counterpart[J].J Am Coll Cardiol, 1993, 21:183A. Abstract.
  • 10Goldstein RN, Khrestian C, Carlsson L, et al. Azd7009: a new antiarrhythmic drug with predominant effects on the atria effectively terminates and prevents reinduction of atrial fibrillation and flutter in the sterile pericarditis model[J]. J Cardiovasc Electrophysiol, 2004, 15 ( 12): 1444-1450.

共引文献47

同被引文献393

引证文献52

二级引证文献161

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部